retatrutide clinical trial results weight loss 2024 2025 press release

retatrutide clinical trial results weight loss 2024 2025 press release Early data for demonstrates exceptional results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under Retatrutide Results: 28.3% Weight Loss

Name: retatrutide clinical trial results weight loss 2024 2025 press release Early data for demonstrates exceptional results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under Retatrutide Results: 28.3% Weight Loss
Brand: 2m-capital.com
SKU: 54563189938
Price: 26.30 USD
Availability: InStock
Rating: 4.1935 (5 reviews)

SKU: 54563189938

4.2

USD26.30 USD62.30

Pay in 4 interest-free payments of $6.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 12 - Nov 17

Description

J Clin Invest 89 : 19081913 Ethics declarations Competing interests The authors declare no competing financial interests

PMID: 39776294

Higher protein intake (1.071.60 g/kg/day) preserved an additional 0.43 kg of lean mass and maintained 142 kcal/day more resting energy expenditure compared to standard protein

Additionally, a clinical study involving 142 participants showed that daily consumption of yerba mate led to a 9.7% increase in serum paraoxonase-1 (PON-1) levels, an enzyme associated with antioxidant protection and cardiovascular benefits